B16-F10 Cells

The B16-F10 cell line is a subline of the murine B16 melanoma cell line, derived from a spontaneous skin tumor in a mouse. These cells are characterized by their aggressive metastatic potential, particularly to the lungs, making them a valuable model for studying melanoma progression and metastasis. The B16-F10 cells exhibit high melanin content, which contributes to their pigmentation and is used as a marker in various assays to track cell proliferation and tumor growth. B16-F10 was obtained through a ten-time selective procedure using Fidler’s method, enhancing its metastatic capability compared to its parent line, B16-F0, and the B16-F1 subline, which underwent a one-time selective procedure.
B16-F10 cells are widely used in cancer research due to their ability to form tumors in syngeneic C57BL/6 mice, providing a consistent and reproducible model for in vivo studies. These cells express various melanoma-associated antigens, which are crucial for investigating immune responses and developing immunotherapies. Additionally, B16-F10 cells are used to evaluate the efficacy of chemotherapeutic agents and the molecular mechanisms underlying drug resistance in melanoma. The cell line’s genetic profile and behavior under different experimental conditions offer insights into the pathways involved in melanoma metastasis, aiding in the development of targeted therapeutic strategies. It is noteworthy that B16-F10’s derivative, B16-BL6, exhibits even greater invasive activity, making the B16 series a comprehensive model system for studying different aspects of melanoma biology and therapy.